Saatja: "ECDC respiratory viruses" <
[email protected]>
Saaja: "Indra Alexander" <
[email protected]>, "Apfalter Petra" <
[email protected]>, "Wesley.Mattheus" <
[email protected]>, "steven.vangucht" <
[email protected]>, "ivanoov" <
[email protected]>, "stefka.krumova" <
[email protected]>, "ljiljana.zmak" <
[email protected]>, "selma.bosnjak" <
[email protected]>, "Ivana Ferenčak" <
[email protected]>, "m.mendris" <
[email protected]>, "Fani Theophanous" <
[email protected]>, "dpieridou" <
[email protected]>, "ckaragiannis" <
[email protected]>, "Barbora Macková" <
[email protected]>, "pavla.krizova" <
[email protected]>, "Kristina Træholt Franck" <
[email protected]>, "Eva Møller Nielsen" <
[email protected]>, "Salmenlinna Saara" <
[email protected]>, "Savolainen-Kopra Carita" <
[email protected]>, "Mathieu TOURDJMAN" <
[email protected]>, "CASTRO-ALVAREZ Javier" <
[email protected]>, "mankertza" <
[email protected]>, "WernerG" <
[email protected]>, "Ιωάννα Σπηλιοπούλου" <
[email protected]>,
[email protected], "Judit Henczkó" <
[email protected]>, "Kristjan Orri Helgason" <
[email protected]>, "Hannes Bjarki Vigfússon" <
[email protected]>, "Kirsten Schaffer" <
[email protected]>, "ARHAI HPSC" <
[email protected]>, "annateresa.palamara" <
[email protected]>, "Stefanelli Paola" <
[email protected]>, "gatis.pakarna" <
[email protected]>, "Walser-Domjan Esther" <
[email protected]>, "Visscher Carla" <
[email protected]>, "svajune.muralyte" <
[email protected]>, "Jonas Žvirgždas" <
[email protected]>, "Trung Nguyen" <
[email protected]>, "claire.marantidis-cordina" <
[email protected]>, "christopher.barbara" <
[email protected]>, "Titia Kortbeek" <
[email protected]>, "bettie.voordouw" <
[email protected]>, "Trine Marie LAbée-Lund Normann" <
[email protected]>, "Christine Genevieve Monceyron Jonassen" <
[email protected]>, "Karoline Bragstad" <
[email protected]>, "Gierczyński Rafał" <
[email protected]>, "a.skoczynska" <
[email protected]>, "Helena Cortes Martins" <
[email protected]>, "Jorge Machado" <
[email protected]>, "Raluca Gatej" <
[email protected]>, "teodora.vremera" <
[email protected]>, "edita.staronova" <
[email protected]>, "lucia.madarova" <
[email protected]>, "Tjaša Žohar Čretnik" <
[email protected]>, "Andrej Steyer" <
[email protected]>, "katarina.prosenc" <
[email protected]>, "ijado" <
[email protected]>, "Horacio Gil Gil" <
[email protected]>, "sara.byfors" <
[email protected]>, "Andreas.Brave" <
[email protected]>, "Költringer Fiona" <
[email protected]>, "monika.redlberger" <
[email protected]>, "Claire Brugerolles" <
[email protected]>, "Nathalie Bossuyt" <
[email protected]>, "Ivelina Trifonova" <
[email protected]>, "korsun" <
[email protected]>, "maja.ilic" <
[email protected]>, "goranka.petrovic" <
[email protected]>, "Stalo Zani" <
[email protected]>, "Christopher Haralambous" <
[email protected]>, "m.mendris" <
[email protected]>, "Despo Constantinou" <
[email protected]>, "Tonia Adamidi" <
[email protected]>, "Helena Jirincova" <
[email protected]>, "Jan Kynčl" <
[email protected]>, "Hanne-Dorthe Emborg" <
[email protected]>, "Ramona Trebbien" <
[email protected]>, "Julia Geller" <
[email protected]>, "olga.sadikova" <
[email protected]>, "Hanna Nohynek" <
[email protected]>, "Niina Ikonen" <
[email protected]>, "Anna MAISA" <
[email protected]>, "Sibylle BERNARD-STOECKLIN" <
[email protected]>, "PARENT Isabelle" <
[email protected]>, "budas" <
[email protected]>, "haasw" <
[email protected]>, "k.papadima" <
[email protected]>, "a.andreopoulou" <
[email protected]>, "molnar.zsuzsanna" <
[email protected]>, "Agnes Danielisz" <
[email protected]>, "Brynja Ármannsdóttir" <
[email protected]>, "Guðrún Erna Baldvinsdóttir" <
[email protected]>, "Kamilla Sigríður Jósefsdóttir - Landl" <
[email protected]>, "Lisa Domegan" <
[email protected]>, "Eve Robinson" <
[email protected]>, "Puzelli Simona" <
[email protected]>, "Mateo Urdiales Alberto" <
[email protected]>, "Karīna Venediktova" <
[email protected]>, "Walser-Domjan Esther" <
[email protected]>, "Visscher Carla" <
[email protected]>, "Ginreta Megelinskienė" <
[email protected]>, "Greta Gargasienė" <
[email protected]>, "svajune.muralyte" <
[email protected]>, "Joël Mossong" <
[email protected]>, "Gérard Scheiden" <
[email protected]>, "Lautier Elaine at Health Regulation" <
[email protected]>, "Melillo Tanya at Health Regulation" <
[email protected]>, "Rianne van Gageldonk-Lafeber" <
[email protected]>, "Adam Meijer" <
[email protected]>, "Trine Hessevik Paulsen" <
[email protected]>, "Hungnes, Olav" <
[email protected]>, "Paradowska-Stankiewicz Iwona" <
[email protected]>, "Pedro Ferreira" <
[email protected]>, "cristina.barbara" <
[email protected]>, "rodica.popescu" <
[email protected]>,
[email protected], "edita.staronova" <
[email protected]>, "ivan.bakoss" <
[email protected]>, "maja.socan" <
[email protected]>, "eva.grilc" <
[email protected]>, "Susana Monge Corella" <
[email protected]>, "Francisco Pozo Sanchez" <
[email protected]>, "Lena Dillner" <
[email protected]>, "anneli.carlander" <
[email protected]>
Teema: Follow up: To NFPs for action: Invitation to participate in technical meeting – Public health laboratory preparedness for respiratory infections (ECDC)
Kuupäev: 2025-03-13 12:27
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu
saatja korral palume linke ja faile mitte avada.
Dear colleagues,
Thank you for those that have signed up to the meeting – registration is now
closed.
A consultation link is available for those who could not attend. This is to
supplement the information that will be collected during the technical
meeting.
The consultation will be open until 1 week after the meeting.
https://www.smartsurvey.co.uk/s/RAND_Europe_ECDC_consultation/
<https://protect2.fireeye.com/v1/url?k=31323334-501d5122-31321d63-454445555731-ba43b88efcc99326&q=1&e=404e36c8-311d-4832-9389-2892b8c3e82b&u=https%3A%2F%2Fwww.smartsurvey.co.uk%2Fs%2FRAND_Europe_ECDC_consultation%2F>
Thank you very much for your participation.
Best wishes,
The ECDC Respiratory viruses and Legionella group
European Centre for Disease Prevention and Control (ECDC)Gustav III:s boulevard 40, 169 73 Solna, Sweden
Phone +46 (0)8 58 60 10 00
<https://www.ecdc.europa.eu/> www.ecdc.europa.eu
Follow ECDC on:
<http://www.facebook.com/ECDC.EU>
<https://bsky.app/profile/ecdc.europa.eu>
<http://www.linkedin.com/company/ecdc>
<http://www.youtube.com/user/ECDCchannel>
<https://www.instagram.com/ecdc.eu>
<https://www.threads.net/@ecdc.eu>
Classified as ECDC NORMAL
From: ECDC respiratory viruses <
[email protected]>
Sent: 07 February 2025 17:32
Subject: To NFPs for action: Invitation to participate in technical
meeting – Public health laboratory preparedness for respiratory infections
(ECDC)
To: National Focal Points for Viral Respiratory Diseases, National
Focal Points for Microbiology
Cc: National Coordinators, Operational Contact Points for COVID-19 and
influenza (Microbiology)
Dear colleagues,
We are reaching out regarding a study that RAND Europe is conducting on the
preparedness of public health laboratories for respiratory infectious
diseases, commissioned and funded by the European Centre for Disease
Prevention and Control (ECDC). We are now organising a technical meeting
related to that study together with RAND Europe. This study is looking at
challenges public health laboratories faced during the COVID-19 pandemic,
how they were resolved, how to sustain advances made during the pandemic,
and ways to improve long-term preparedness in public health laboratories for
future respiratory infections.
As part of this study, RAND Europe and ECDC will be conducting a technical
meeting on Tuesday 18th of March from 10am-3pm CET (9am -2pm GMT). This
technical meeting is organised to gather further insights from the countries
on laboratory preparedness following the survey and interviews that were
conducted in December 2024. During the meeting participants will learn about
initial findings from this study, based on a literature review and data
collection from public health contact points across EU/EEA countries.
Participants will be asked to reflect on findings, provide feedback, and
discuss views with facilitators and other participants. Topics of discussion
will include the effectiveness of different solutions implemented during the
pandemic, strategies to sustain advances and measures improve preparedness
in public health laboratories.
Two representants per EU/EEA Member State are being invited to partake in
the meeting alongside wider public health stakeholders (e.g. from the
European Commission, ECDC). The participants could be the people who
answered the survey or who were interviewed, or other people among the
official contact points (NFPs, NMFP, OCPs). We would be grateful if, as NFP
or NMFP, you could evaluate who, among yourselves and the Operational
Contact Points for COVID-19 and influenza (Microbiology), would be best
suited to represent your country and to contribute to the discussions during
this meeting. The meeting will take approximately 5 hours, including a
1-hour lunch break. Due to the limited number of participants we can
accommodate, we kindly request that you discuss the topic with colleagues as
needed in order to be able to participate in conversation during the day of
the event.
More information about the content of the meeting can be find in in the
attached Participant Information Sheet. The preliminary agenda is also
available for your information at the end of this email. If you have any
questions about the meeting or the study, please contact the ECDC or RAND
Europe teams.
We are thanking you in advance for taking the time to consider this request.
The nominations should be sent to ECDC at
[email protected]
<mailto:
[email protected]> and cc to RAND Europe (Saoirse
Moriarty at
[email protected] <mailto:
[email protected]> ;
Katie Sykes at
[email protected] <mailto:
[email protected]> ) by 17
February 2025.
Best regards,
The ECDC Respiratory Viruses and Legionella team
and Sarah Parkinson on behalf of RAND Europe
--
Preliminary Agenda of the 18th March’s technical meeting:
Time (CET)
Agenda item
10-10:15
Welcome and introductions
10:15-10:45
Preliminary findings
10:45-11:10
Plenary 1 – Reflections on findings
11:10-12:00
Breakout 1 – Challenges and solutions
12:00-1:00
Lunch break
1:00-2:00
Breakout 2 – Sustaining advances and improving preparedness
2:00-2:10
Plenary 2 - Feedback from breakout rooms
2:10-2:50
Plenary 3 - Prioritisation of lessons from COVID-19
2:50-3:00
Next steps and close
European Centre for Disease Prevention and Control (ECDC)Gustav III:s boulevard 40, 169 73 Solna, Sweden
Phone +46 (0)8 58 60 10 00
<https://www.ecdc.europa.eu/> www.ecdc.europa.eu
Follow ECDC on:
<http://www.facebook.com/ECDC.EU>
<https://bsky.app/profile/ecdc.europa.eu>
<http://www.linkedin.com/company/ecdc>
<http://www.youtube.com/user/ECDCchannel>
<https://www.instagram.com/ecdc.eu>
<https://www.threads.net/@ecdc.eu>
Confidentiality Notice
If you are not the intended recipient of this message, you are hereby kindly
requested, to, consecutively, refrain from disclosing its content to any
third party, delete it and inform its sender of the erroneous transmittal.